12 results on '"Shang X"'
Search Results
2. 300P The clinical results of an investigator initiated trial of allogeneic CAR-T cells targeting IL13Rα2 in the treatment of high-grade glioma
3. 298P Stable, controllable, and scalable manufacturing of B7-H3 UCAR-T, an allogeneic CAR-T product for advanced glioma, from healthy donors
4. 1805P PKD1L1 mutations in small cell lung cancer: A genomic signature for poor prognosis and drug susceptibility
5. 1019P Bispecific PD1-IL2 antibody reshapes the inhibitory immune microenvironment of SMARCA4 mutant non-small cell lung cancer by reversing CD8+T cell exhaustion
6. LBA3 Safety and efficacy of pembrolizumab combined with paclitaxel and cisplatin as a neoadjuvant treatment for locally advanced resectable (stage III) esophageal squamous cell carcinoma (Keystone-001): Interim analysis of a prospective, single-arm, single-center, phase II trial
7. 166TiP Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed surgery for locally advanced esophageal squamous cell carcinoma: Protocol for a multi-center, prospective, randomized-controlled, phase III clinical study (Keystone-002)
8. 1303P A clinical variable based nomogram could predict survival for NSCLC patients receiving atezolizumab
9. 1186P Study on possible mechanisms of HPD associated with the amplification of chromosome 11q13 in NSCLC
10. 1558P Preoperative pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma (ESCC): The phase II Keystone-001 trial
11. 1789P Fewer liver and lymph node metastases may contribute to survival benefits for patients with c-SCLC compared with SCLC
12. 1220P Proposals for revision of N descriptors in the forthcoming edition of TNM staging for NSCLC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.